课题基金 / 基金详情

RESIDUAL LEUKEMIA LEVELS DURING SECOND REMISSION IN ALL

RESIDUAL LEUKEMIA LEVELS DURING SECOND REMISSION IN ALL
第二次缓解期间所有患者的残余白血病水平
批准号：
2822593
负责人：
THEODORE F ZIPF
金额：
$9.84万
依托单位：
UNIVERSITY OF TX MD ANDERSON CAN CTR
依托单位国家：
美国
项目类别：
财政年份：
1996
资助国家：
美国
项目状态：
已结题
起止时间：
1996-07-01 至 1999-06-30
来源：
https://reporter.nih.gov/project-details/2822593
关键词：
RNA acute lymphocytic leukemia bioassay bone marrow bone marrow transplantation child (0-11) clinical research cytogenetics gene rearrangement graft versus host disease human genetic material tag human subject human therapy evaluation longitudinal human study neoplasm /cancer chemotherapy neoplasm /cancer relapse /recurrence neoplasm /cancer remission /regression neoplasm /cancer transplantation neoplastic cell nucleic acid sequence pediatric neoplasm /cancer pediatric pharmacology polymerase chain reaction statistics /biometry tissue /cell culture

项目成果

THEODORE F ZIPF的其他基金

相似基金

相关文献

期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Residual leukaemia after bone marrow transplant in children with acute lymphoblastic leukaemia after first haematological relapse or with poor initial presenting features.
首次血液学复发或初始表现不佳的急性淋巴细胞白血病儿童骨髓移植后残留白血病。
DOI： 10.1046/j.1365-2141.2003.04135.x
发表时间： 2003
期刊： British journal of haematology
影响因子： 6.5
作者： [Bunin,Nancy, Johnston,DennisA, Roberts,WMark, Ouspenskaia,MaiaV, Papusha,VictorZ, Brandt,MarkA, Zipf,TheodoreF]
通讯作者： Zipf,TheodoreF
RESIDUAL LEUKEMIA LEVELS DURING SECOND REMISSION IN ALL
RESIDUAL LEUKEMIA LEVELS DURING SECOND REMISSION IN ALL
海外基金